Business ❯ Pharmaceutical Industry

Licensing Agreements

Partnerships Financial Transactions Drug Partnerships International Partnerships Generic Production Global Collaborations International Deals Drug Commercialization Strategic Partnerships Collaboration Agreements Biotechnology Lupin Pharmaceuticals Collaboration Collaborations Clinical Development

AstraZeneca Strikes $1.2 Billion CSPC Pact for Once‑Monthly Obesity and Diabetes Programs

The lead asset SYH2082 is progressing into Phase 1 following the signing.

Pfizer Licenses Early-Stage Oral GLP-1 From YaoPharma in Up to $2 Billion Deal

Novo Nordisk Licenses Omeros’ MASP-3 Drug in Deal Worth Up to $2.1 Billion

GSK Closes $12 Billion Licensing Pact for Hengrui’s COPD Therapy and 11 Preclinical Assets